Foster Children: HHS Could Provide Additional Guidance to States Regarding Psychotropic Medications.
United States Government Accountability Office.
U.S. Government Accountability Office (GAO)
441 G St., NW
Washington, DC 20548
Tel: (202) 512-6000 (Publications) (202) 512-3000 (Locator)
Fax: (202) 512-6061
TDD/TTY: (202) 512-2537
This report discusses the findings of a study commissioned by the Government Accountability Office that reviewed foster and medical records for 24 cases of foster children receiving psychotropic medication in five selected States. The study found varying quality in the documentation supporting the use of psychotropic medications for children in foster care. It found that for many of the cases the prescriptions were mostly supported by documentation, however in some areas documentation was lacking. A recommendation is made that the Secretary of Health and Human Services (HHS) issue guidance to State Medicaid, child-welfare, and mental-health officials regarding prescription-drug monitoring and oversight for children in foster care receiving psychotropic medications through MCOs. It is noted that HHS concurred with the recommendations and described planned actions.
foster children; psychotropic medication; Drug therapy; Mental health services; Documentation; Guidelines